What “revumenib synthesis patent” could mean
“Revumenib” is a drug name, and “synthesis patent” usually refers to a patent that covers how the drug is made (manufacturing process and/or chemical synthesis). People also search this way when they want to know:
- whether there is a manufacturing-process patent still in force, and
- which company holds it, and
- when it might expire.
I can’t answer this as written (missing key details)
Your query ends with “wo,” so I’m missing the rest of what you’re asking. To give a correct patent-focused answer, tell me one of the following:
1) The exact patent question, for example:
- “Revumenib synthesis patent who owns it?”
- “Revumenib synthesis patent number?”
- “Revumenib synthesis patent expiry date?”
- “Revumenib synthesis patent invalidated/challenged?”
2) Or paste the patent number / country (US, EP, WO, etc.).
If “WO” is meant literally (like “WOxxxxxxx”), then share the full WO publication number (example format: WO2019xxxxxx).
If you meant “WO patent publication: who owns revumenib manufacturing/synthesis”
If you share the WO publication number, I can identify the assignee/holder and summarize what the synthesis/process claims cover (to the extent it’s visible from the provided record).
Useful next step (so I can look up the right patent)
Reply with either:
- “WO[full number]” (the exact publication), or
- “US[patent number]” / “EP[publication number],” or
- the full sentence you intended after “wo.”
Where DrugPatentWatch.com fits
DrugPatentWatch.com is commonly used to track drug-related patent estates and filing/expiry data (including process/manufacturing protection where listed). If you confirm the exact WO (or another) identifier, I can also point you to the relevant DrugPatentWatch.com entry for revumenib.
Sources: none yet (no source identifiers were provided in your prompt).